Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
BackgroundMyriad roles for high-density lipoprotein (HDL) beyond atheroprotection include immunologic functions implicated in the severity of coronavirus disease-2019 (COVID-19) in adults. We explored whether there is an association between HDL and COVID-19 severity in youth.MethodsA pediatric cohor...
| Published in: | Frontiers in Cardiovascular Medicine |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1033660/full |
| _version_ | 1852692827319828480 |
|---|---|
| author | Michele Mietus-Snyder Michele Mietus-Snyder Michele Mietus-Snyder Michele Mietus-Snyder William Suslovic Meghan Delaney Meghan Delaney Meghan Delaney Martin P. Playford Rami A. Ballout John R. Barber James D. Otvos Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Nehal N. Mehta Alan T. Remaley Alan T. Remaley |
| author_facet | Michele Mietus-Snyder Michele Mietus-Snyder Michele Mietus-Snyder Michele Mietus-Snyder William Suslovic Meghan Delaney Meghan Delaney Meghan Delaney Martin P. Playford Rami A. Ballout John R. Barber James D. Otvos Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Nehal N. Mehta Alan T. Remaley Alan T. Remaley |
| author_sort | Michele Mietus-Snyder |
| collection | DOAJ |
| container_title | Frontiers in Cardiovascular Medicine |
| description | BackgroundMyriad roles for high-density lipoprotein (HDL) beyond atheroprotection include immunologic functions implicated in the severity of coronavirus disease-2019 (COVID-19) in adults. We explored whether there is an association between HDL and COVID-19 severity in youth.MethodsA pediatric cohort (N = 102), who tested positive for COVID-19 across a range of disease manifestations from mild or no symptoms, to acute severe symptoms, to the multisystem inflammatory syndrome of children (MIS-C) was identified. Clinical data were collected from the medical record and reserve plasma aliquots were assessed for lipoproteins by NMR spectroscopy and assayed for HDL functional cholesterol efflux capacity (CEC). Findings were compared by COVID-19 status and symptom severity. Lipoprotein, NMR spectroscopy and CEC data were compared with 30 outpatient COVID negative children.ResultsDecreasing HDL cholesterol (HDL-c), apolipoprotein AI (ApoA-I), total, large and small HDL particles and HDL CEC showed a strong and direct linear dose-response relationship with increasing severity of COVID-19 symptoms. Youth with mild or no symptoms closely resembled the uninfected. An atypical lipoprotein that arises in the presence of severe hepatic inflammation, lipoprotein Z (LP-Z), was absent in COVID-19 negative controls but identified more often in youth with the most severe infections and the lowest HDL parameters. The relationship between HDL CEC and symptom severity and ApoA-I remained significant in a multiply adjusted model that also incorporated age, race/ethnicity, the presence of LP-Z and of GlycA, a composite biomarker reflecting multiple acute phase proteins.ConclusionHDL parameters, especially HDL function, may help identify youth at risk of more severe consequences of COVID-19 and other novel infectious pathogens. |
| format | Article |
| id | doaj-art-7e5f7ab623b341c6bbba59110c3d23fc |
| institution | Directory of Open Access Journals |
| issn | 2297-055X |
| language | English |
| publishDate | 2022-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| spelling | doaj-art-7e5f7ab623b341c6bbba59110c3d23fc2025-08-19T21:23:56ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-10-01910.3389/fcvm.2022.10336601033660Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severityMichele Mietus-Snyder0Michele Mietus-Snyder1Michele Mietus-Snyder2Michele Mietus-Snyder3William Suslovic4Meghan Delaney5Meghan Delaney6Meghan Delaney7Martin P. Playford8Rami A. Ballout9John R. Barber10James D. Otvos11Roberta L. DeBiasi12Roberta L. DeBiasi13Roberta L. DeBiasi14Roberta L. DeBiasi15Roberta L. DeBiasi16Nehal N. Mehta17Alan T. Remaley18Alan T. Remaley19Children's National Hospital, Washington, DC, United StatesThe Children's National Clinical and Translational Science Institute, Washington, DC, United StatesDivision of Cardiology, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesDepartment of Pediatrics, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesChildren's National Hospital, Washington, DC, United StatesChildren's National Hospital, Washington, DC, United StatesDepartment of Pediatrics, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesDivision of Clinical and Laboratory Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesCardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD, United StatesLipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United StatesThe Children's National Clinical and Translational Science Institute, Washington, DC, United StatesLipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United StatesChildren's National Hospital, Washington, DC, United StatesThe Children's National Clinical and Translational Science Institute, Washington, DC, United StatesDepartment of Pediatrics, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesDivision of Infectious Diseases, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesDepartment of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, United StatesCardiovascular and Pulmonary Branch, National Institutes of Health, Bethesda, MD, United StatesLipoprotein Metabolism Section, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States0Clinical Center, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, United StatesBackgroundMyriad roles for high-density lipoprotein (HDL) beyond atheroprotection include immunologic functions implicated in the severity of coronavirus disease-2019 (COVID-19) in adults. We explored whether there is an association between HDL and COVID-19 severity in youth.MethodsA pediatric cohort (N = 102), who tested positive for COVID-19 across a range of disease manifestations from mild or no symptoms, to acute severe symptoms, to the multisystem inflammatory syndrome of children (MIS-C) was identified. Clinical data were collected from the medical record and reserve plasma aliquots were assessed for lipoproteins by NMR spectroscopy and assayed for HDL functional cholesterol efflux capacity (CEC). Findings were compared by COVID-19 status and symptom severity. Lipoprotein, NMR spectroscopy and CEC data were compared with 30 outpatient COVID negative children.ResultsDecreasing HDL cholesterol (HDL-c), apolipoprotein AI (ApoA-I), total, large and small HDL particles and HDL CEC showed a strong and direct linear dose-response relationship with increasing severity of COVID-19 symptoms. Youth with mild or no symptoms closely resembled the uninfected. An atypical lipoprotein that arises in the presence of severe hepatic inflammation, lipoprotein Z (LP-Z), was absent in COVID-19 negative controls but identified more often in youth with the most severe infections and the lowest HDL parameters. The relationship between HDL CEC and symptom severity and ApoA-I remained significant in a multiply adjusted model that also incorporated age, race/ethnicity, the presence of LP-Z and of GlycA, a composite biomarker reflecting multiple acute phase proteins.ConclusionHDL parameters, especially HDL function, may help identify youth at risk of more severe consequences of COVID-19 and other novel infectious pathogens.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1033660/fullpediatric COVID-19 severityHDL-cholesterolHDL subspeciesHDL functionNMR lipoprotein analysislipoprotein Z |
| spellingShingle | Michele Mietus-Snyder Michele Mietus-Snyder Michele Mietus-Snyder Michele Mietus-Snyder William Suslovic Meghan Delaney Meghan Delaney Meghan Delaney Martin P. Playford Rami A. Ballout John R. Barber James D. Otvos Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Roberta L. DeBiasi Nehal N. Mehta Alan T. Remaley Alan T. Remaley Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity pediatric COVID-19 severity HDL-cholesterol HDL subspecies HDL function NMR lipoprotein analysis lipoprotein Z |
| title | Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity |
| title_full | Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity |
| title_fullStr | Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity |
| title_full_unstemmed | Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity |
| title_short | Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity |
| title_sort | changes in hdl cholesterol particles and function associate with pediatric covid 19 severity |
| topic | pediatric COVID-19 severity HDL-cholesterol HDL subspecies HDL function NMR lipoprotein analysis lipoprotein Z |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1033660/full |
| work_keys_str_mv | AT michelemietussnyder changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT michelemietussnyder changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT michelemietussnyder changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT michelemietussnyder changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT williamsuslovic changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT meghandelaney changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT meghandelaney changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT meghandelaney changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT martinpplayford changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT ramiaballout changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT johnrbarber changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT jamesdotvos changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT robertaldebiasi changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT robertaldebiasi changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT robertaldebiasi changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT robertaldebiasi changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT robertaldebiasi changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT nehalnmehta changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT alantremaley changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity AT alantremaley changesinhdlcholesterolparticlesandfunctionassociatewithpediatriccovid19severity |
